Veysel Nijat Baş

Veysel Nijat Baş

Auto-generated profile, based on publicly available information

Veysel Nijat Baş

Kütahya Health Sciences University

Research Focus & Metrics

Academic Career Length

15Years (2012-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 January 2012 in Journal of Pediatric Endocrinology and Metabolism
Verified
Journal Article
Closed access
VBVeysel Nijat Baş
Veysel Nijat Baş
HCHakan Cangul
Hakan Cangul
SASebahat Yilmaz Agladioglu
Sebahat Yilmaz Agladioglu
MKMichaela Kendall
Michaela Kendall
SÇSemra Çağlar Çetinkaya
Semra Çağlar Çetinkaya
ZAZehra Aycan
Zehra Aycan
Congenital hypothyroidism (CH) is the most commonly encountered endocrinological birth defect, with an incidence of approximately 1 in 3000-4000 live births. It could be sporadic or familial as well as goitrous or non-goitrous. Inactivating mutations of TSHR , which is one of the genes responsible for non-goitrogenic congenital hypothyroidism, are mostly inherited autosomal recessively and result in a wide clinical spectrum owing to the extent of receptor function loss. Here, we report detailed clinical features of two CH cases with TSHR mutations. The first case was diagnosed before the initiation of the national screening program and had a severe clinical phenotype associated with a homozygous inactivating TSHR mutation (P556R), whereas the second case was diagnosed after the introduction of the national screening program and showed a mild clinical presentation and carried another homozygous missense mutation (P162A) in the TSHR gene. We compared the clinical features of our cases with those of previously reported patients with TSHR mutations to enhance the genotype/phenotype correlations between these mutations and corresponding clinical phenotypes.

15 December 2012 in Journal of Clinical Research in Pediatric Endocrinology
Verified
Journal Article
Open access
IKİlknur Kaba
İlknur Kaba
ZAZehra Aycan
Zehra Aycan
SÇSemra Çağlar Çetinkaya
Semra Çağlar Çetinkaya
VBVeysel Nijat Baş
Veysel Nijat Baş
SASebahat Yılmaz Ağladıoğlu
Sebahat Yılmaz Ağladıoğlu
AÖAşan Önder
Aşan Önder
A combination of Turner syndrome (TS) and classical congenital adrenal hyperplasia (CAH) is rare. A one-day-old newborn was referred to our hospital with ambiguous genitalia. The parents were third-degree relatives. The infant's weight was 3350g (50-75p), and the head circumference was 34.5cm (50p). The gonads were nonpalpable. Presence of a 3 cm phallus, one urogenital opening into the perineum, and incomplete labial fusion were identified. Laboratory tests revealed a classical type of CAH due to 21-hydroxylase deficiency. Karyotyping revealed a 45X0(35)/46XX(22) pattern with negative sex-determining region Y (SRY) on gene analysis. At the most recent follow-up visit, the patient appeared to be in good health - her height was 70.4 cm [-1.5 standard deviation (SD)] and her weight was 9.8 kg (0.3 SD). She was receiving hydrocortisone in a dose of 10 mg/m²/day, fludrocortisone acetate in a dose of 0.075 mg/day, and oral salt of 1 g/day. System examinations were normal. The patient's electrolyte levels were found to be normal and she was in good metabolic control. The findings of this patient demonstrate that routine karyotyping during investigation of patients with sexual differentiation disorders can reveal TS. Additionally, signs of virilism should always be investigated at diagnosis or during physical examinations for follow-up of TS cases. SRY analysis should be performed primarily when signs of virilism are observed. CAH should also be considered in patients with negative SRY.

10 November 2025 in Journal of Pediatric Endocrinology and Metabolism
Verified
Journal Article
Closed access
FCFatmagül Can
Fatmagül Can
VBVeysel N. Baş
Veysel N. Baş
FKFatma E. Koçak
Fatma E. Koçak
İEİlknur Elifoğlu
İlknur Elifoğlu
Objectives: There has been a growing rate of obesity among children and adolescents in recent years. Understanding the molecular mechanisms is crucial for grasping the onset and progression. Adipose tissue is recognized for its role in endocrine functions, releasing adipokines that play a vital role in the metabolic disruptions linked to obesity. Given the involvement of adipokines such as FSTL-1 (follistatin related protein 1), FAM19A5 (family with sequence similarity to 19 member A5), and CTRP-6 (C1q/tumor necrosis factor related protein 6) in this condition, the primary goal of our study was to explore the connection between these adipokines, metabolic parameters, anthropometric data, and obesity. Methods: Seventy-nine children aged 0–10 years with exogenous obesity and 88 healthy children were included in the study. Adipokine levels were measured using ELISA. The relationship between biochemical parameters and anthropometric data was also evaluated. Results: CTRP6 was 6.11 (4.95–8.13) ng/mL in the obese group and 2.79 (1.73–4.58) ng/mL in the healthy control group (p<0.0001); FSLT1 was 157.7 (130.5–216.5) ng/mL in the obese group and 187.4 (151.8–289.6) ng/mL in the healthy control group (p=0.0003), FAM19A5 was 590.8 (476.4–703.9) ng/L in the obese group and 736.8 (491.8–1,719.0) ng/L in the healthy control group (p=0.0003). Conclusions: CTRP6 levels were found to be higher in obese children than in the healthy control group, while FSLT1 and FAM19A5 levels were found to be lower. Changes in the levels of these adipokines may play important roles in obesity and related conditions.

1 August 2022 in Güncel Pediatri
Verified
Journal Article
Closed access
YAYasin Akkuş
Yasin Akkuş
SDSaime Ergen Dibeklioğlu
Saime Ergen Dibeklioğlu
RÖRahmi Özdemir
Rahmi Özdemir
VBVeysel Nijat Baş
Veysel Nijat Baş
MÇMuharrem Çiçek
Muharrem Çiçek

30 June 2025 in Trends in Pediatrics
Verified
Journal Article
Open access
PDF file
İEİlknur Elifoğlu
İlknur Elifoğlu
RÖRahmi Özdemir
Rahmi Özdemir
VBVeysel Nijat Baş
Veysel Nijat Baş
DGDamla Geçkalan
Damla Geçkalan
EŞEmine Değirmen Şişman
Emine Değirmen Şişman
Objective: Type 1 diabetes mellitus is the most common endocrine-metabolic disease in childhood, which progresses with insulin deficiency and can cause serious cardiovascular complications. Atrial and ventricular arrhythmias are important cardiovascular complications of diabetes. In this study, cardiac repolarization inhomogeneity in children with Type 1 diabetes mellitus was evaluated electrocardiographically. Method: Between February 2021 and April 2021, 48 patients with Type 1 diabetes mellitus and an equal number of healthy control groups were included in the study. Demographic characteristics of all cases were analyzed. P wave dispersion (PWd), QT interval (QT), QT dispersion (QTd), QTc interval (QTc), QTc dispersion (QTcd), Tpeak-Tend interval (Tp-e), Tp-e dispersion (Tp-ed) were evaluated with 12-lead electrocardiography, Tp-e/QT, Tp-Te/QTc ratios were calculated, and parameters were compared between both groups. Results: The mean age of the patient group was 11.44 ± 4 years, and the mean age of the control group was 9.97 ± 4.5 years. The study group consisted of 18 girls (37.5%) and 30 boys (62.5%). In the control group, there were 21 girls (43.7%) and 27 boys (56.3%). There was no significant difference between the patient and control groups in terms of age and gender. The disease duration of the cases was 35.10±30.7 months, and the HbA1c value was 8.4±1.75%. When heart rates, P wave duration, and PWd, QT, QTd, QTc, QTcd, Tp-e, Tp-ed values were compared between the patient and control groups, there was no statistically significant difference between the PWd, QT and QTc intervals, QTd, QTcd, Tp-e interval, Tp-e dispersion, Tp-e/QT, Tp-e/QTd measurements and ratios of the two groups (p>0.05). Conclusion: In our study, ventricular repolarization parameters of children with Type 1 diabetes and healthy children were found to be similar. Although we think the data we have obtained will contribute to the literature due to the limited number of studies on this subject in children, we believe that long-term and prospective studies involving more patients are needed.

16 July 2026 in BMC Endocrine Disorders
Verified
Journal Article
Open access
YÖYavuz Özer
Yavuz Özer
HRHatice Ilgın Ruhi
Hatice Ilgın Ruhi
HTHande Turan
Hande Turan
MKMelikşah Keskin
Melikşah Keskin
SSSezgin Sahin
Sezgin Sahin
OEOlcay Evliyaoglu
Olcay Evliyaoglu
Children with idiopathic short stature (ISS) have reduced height potential without identifiable endocrine or systemic causes. Selecting appropriate candidates for recombinant human growth hormone (rhGH) therapy remains challenging. The aim of this study was to describe near-final height (NFH) outcomes and to identify clinical predictors of growth response in children with ISS who were selected for rhGH therapy based on a positive IGF-1 generation test (IGFGT). In this multicenter retrospective study (2009-2018) across four centers in Türkiye, patients diagnosed with ISS, baseline IGF-1 < 0 SDS, and ≥ 20% IGF-1 increment after IGFGT were included. GH1 gene sequencing was performed to exclude biologically inactive GH, a condition marked by normal or elevated GH secretion but impaired biological activity. NFH was defined as bone age ≥ 14 years in girls and ≥ 16 years in boys. Height SDS gain from baseline to NFH was evaluated. Sixty-three patients (28 females, 19 pubertal) were enrolled, of whom 55 had NFH data and were included in the final analysis. Mean age at treatment initiation was 10.8 ± 3.0 years. No GH1 mutations were identified. Among 55 patients with NFH data, mean height SDS increased from - 2.90 ± 0.77 at baseline to -1.92 ± 0.90 at NFH (p < 0.001), with a mean height SDS gain of 0.93 ± 0.68. The median difference between NFH SDS and baseline predicted adult height (PAH) SDS was - 0.06 (- 0.32-0.07). Predictors of NFH gain included female gender, target height (TH) SDS, baseline height-TH difference, baseline height-PAH difference, and first-year growth velocity SDS. rhGH therapy was associated with improvements in height SDS and NFH in this selected cohort of children with ISS. However, the absence of an untreated control group and the minimal difference between NFH and baseline PAH indicate that these findings should be interpreted with caution. Although no GH1 mutations were identified, the relatively high rate of parental consanguinity suggests that other genetic factors within the GH-IGF-1 axis or epiphyseal growth plate pathways may underlie the etiology of short stature. Not applicable.